Lensfree microscopy at CES 2020: bedside analysis and pathology screening

CEA-Leti Will Demonstrate Next-Generation Technology that Enables Bedside Diagnosis of Disease at One-Tenth the Cost of Bulky Optical Microscopes. GRENOBLE, France - Dec. Miniaturization of sophisticated technologies has opened the door to innovative health-and-safety equipment that enables advances such as onsite, immediate evaluation of environmental risks and patient-sample analysis outside the lab. French research institute CEA-Leti's lensfree microscope for diagnosing spinal meningitis at a fraction of the cost of bulky existing systems is the latest breakthrough in this field. The microscope, which will be demonstrated at CES 2020, can be operated by healthcare professionals at the patient's bedside. It provides immediate results and accurate countings of white blood cells (leukocytes) in cerebrospinal fluid, which is required to diagnose spinal meningitis, an acute inflammation of the membranes covering the brain and spinal cord. Results in One Minute The technology costs about one-tenth as much as an optical microscope and can image up to 10,000 microscopic biological objects at a time.